Fortress Biotech, Inc. (NASDAQ: FBIO) Featured in Virtual Coverage of the 34th Annual Roth Conference
Fortress Biotech, Inc. (NASDAQ: FBIO) is engaged in the acquisition, development and commercialization of high-potential marketed and development-stage drugs and drug candidates in six large-market areas, including oncology, rare diseases and gene therapy. The innovative biopharmaceutical company currently has nine marketed prescription pharmaceutical products and more than thirty programs in development at Fortress, at its majority-owned and majority-controlled partners and at partners it founded and…